Rheumatoid arthritis gene therapy - University of PittsburghAlternative Names: IL-1Ra gene therapy
Latest Information Update: 21 Jan 2004
At a glance
- Originator University of Pittsburgh Medical Center
- Class Antirheumatics; Gene therapies
- Mechanism of Action Interleukin 1 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Rheumatoid arthritis